Ameritas Investment Partners, Inc. Celldex Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,544 shares of CLDX stock, worth $128,524. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,544
Previous 6,544
-0.0%
Holding current value
$128,524
Previous $222,000
25.68%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$99.5 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$92.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$76.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.7 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$69.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $919M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...